MetLife Investment Management’s Impax Laboratories, Inc. IPXL Stock Holding History

MetLife Investment Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-35,866	Closed	-$698K	–	2275
2018 Q1	$698K	Hold	35,866	–	–	0.01%	1171
2017 Q4	$597K	Buy	+35,866	New	+$657K	0.01%	1308

MetLife Investment Management's IPXL Position: Q2 2018 in Review

MetLife Investment Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 35,866 shares — an estimated $698K sold.

MetLife Investment Management first reported a position in IPXL in Q4 2017 and held it in 2 quarters. The position peaked at $698K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

MetLife Investment Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
MetLife Investment Management sold 35,866 Impax Laboratories, Inc. shares in Q2 2018, an estimated $698K.
MetLife Investment Management first reported a position in Impax Laboratories, Inc. in Q4 2017 and held it in 2 quarters.
MetLife Investment Management's Impax Laboratories, Inc. position peaked at $698K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on MetLife Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.